Answers are grounded in this paper and cite their sources.
International Journal of Pharmacology and Clinical Sciences,2023,12,4,187-188.DOI:10.5530/ijpcs.2023.12.25Published:February 2024Type:Research ArticleAuthors:Juman Alsaab Author(s) affiliations:Juman Alsaab, Pharm D, Ministry of Health, Riyadh, SAUDI ARABIA. Abstract:Registrations: It had been registered in the following countries: United Kingdom (U.K.), United States of America (USA), Canada, and Saudi Arabia (SA). Trade name (USA.); VIVJOA ® Registration number (S.A.): Not available Insurance Drug Formulary (S.A.): Not available General Information: Registered Company: Mycovia Pharmaceuticals, Inc. Regulatory Status: R.X. Mechanism of Action: Inhibitor targeting the fungal sterol by inhibition of CYP51 results accumulation of 14-methylated sterols, which are toxic to fungi. Read more... View:PDF (189.05 KB) PDFClick here to download the PDF file.
No takes yet. Share an insight, caveat, or question.
Juman Alsaab (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: